KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 55 filers reported holding KALA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $16,000 | -93.5% | 52,513 | -70.4% | 0.00% | – |
| Q1 2022 | $246,000 | -41.7% | 177,561 | -49.1% | 0.00% | – |
| Q4 2021 | $422,000 | -50.1% | 348,646 | +8.1% | 0.00% | – |
| Q3 2021 | $845,000 | -63.2% | 322,415 | -25.6% | 0.00% | – |
| Q2 2021 | $2,297,000 | -46.4% | 433,506 | -31.8% | 0.00% | – |
| Q1 2021 | $4,282,000 | -50.2% | 635,292 | -49.9% | 0.00% | – |
| Q4 2020 | $8,592,000 | +96.7% | 1,267,224 | +117.5% | 0.00% | -100.0% |
| Q3 2020 | $4,369,000 | +91.0% | 582,563 | +167.7% | 0.00% | – |
| Q2 2020 | $2,287,000 | -47.1% | 217,634 | -55.7% | 0.00% | -100.0% |
| Q1 2020 | $4,322,000 | +483.3% | 491,600 | +144.7% | 0.00% | – |
| Q4 2019 | $741,000 | +16.1% | 200,935 | +19.9% | 0.00% | – |
| Q3 2019 | $638,000 | +49.8% | 167,539 | +151.6% | 0.00% | – |
| Q2 2019 | $426,000 | -7.6% | 66,600 | -29.4% | 0.00% | – |
| Q4 2018 | $461,000 | +17.0% | 94,300 | +136.3% | 0.00% | – |
| Q3 2018 | $394,000 | -69.6% | 39,900 | -57.7% | 0.00% | – |
| Q2 2018 | $1,297,000 | +52.6% | 94,400 | +75.8% | 0.00% | – |
| Q1 2018 | $850,000 | +282.9% | 53,700 | +451.3% | 0.00% | – |
| Q3 2017 | $222,000 | – | 9,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,333,333 | $5,073,000 | 100.00% |
| CAXTON CORP | 1,483,343 | $5,644,000 | 6.36% |
| Polaris Venture Management Co. V, L.L.C. | 1,197,032 | $4,555,000 | 2.59% |
| RA Capital Management | 4,537,478 | $17,265,000 | 1.03% |
| Orbimed Advisors | 3,447,840 | $13,119,000 | 0.25% |
| Matisse Capital | 46,500 | $177,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 332,831 | $1,266,000 | 0.22% |
| Sofinnova Investments, Inc. | 478,206 | $1,819,000 | 0.16% |
| HARBOURVEST PARTNERS LLC | 99,186 | $377,000 | 0.16% |
| ALGERT GLOBAL LLC | 47,195 | $180,000 | 0.07% |